{"id":4035,"date":"2011-04-11T13:58:00","date_gmt":"2011-04-11T13:58:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=4035"},"modified":"2021-07-09T11:22:18","modified_gmt":"2021-07-09T11:22:18","slug":"treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/","title":{"rendered":"Treatment of refractory Crohn’s disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases"},"content":{"rendered":"
\n

Shingo Kato<\/a> 1<\/a><\/sup>, Kazuhito Kani<\/a>, Hidehiko Takabayashi<\/a>, Ryuichi Yamamoto<\/a>, Tomonari Ogawa<\/a>, Akihiko Matsuda<\/a>, Koji Yakabi<\/a>, Intern ed. 2011;50(15):1591-3.<\/p>\n<\/div>\n\n

\n

Granulocyte and monocyte adsorption apheresis (GMA) is one therapeutic option for induction of remission in patients with inflammatory bowel diseases. Recently intensive GMA (2 sessions per week) was reported to be strikingly better than weekly GMA, both in remission rate and time to remission. Here we report two cases of Crohn’s disease refractory to weekly GMA who responded to intensive GMA. One patient had not received immunosuppressive therapy while the other had been refractory to combination therapy with infliximab and azathioprine. Intensive GMA induced remission in these 2 patients. Intensive GMA may represent a therapeutic choice for remission induction and maintenance with infliximab.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/21804287\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/50\/15\/50_15_1591\/_pdf\/-char\/en<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Shingo Kato 1, Kazuhito Kani, Hidehiko Takabayashi, Ryuichi Yamamoto, Tomonari Ogawa, Akihiko Matsuda, Koji Yakabi, Intern ed. 2011;50(15):1591-3. Granulocyte and monocyte adsorption apheresis (GMA) is one therapeutic option for induction of remission in patients with inflammatory bowel diseases. Recently intensive GMA (2 sessions per week) was reported to be strikingly better than weekly GMA, both in remission rate and time to remission. […]<\/p>\n","protected":false},"template":"","scientific_tags":[276,147,53],"class_list":["post-4035","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-cases","scientific_tags-clinical-remission","scientific_tags-refractory-patients"],"acf":{"sc_authors":""},"yoast_head":"\nTreatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Shingo Kato 1, Kazuhito Kani, Hidehiko Takabayashi, Ryuichi Yamamoto, Tomonari Ogawa, Akihiko Matsuda, Koji Yakabi, Intern ed. 2011;50(15):1591-3. Granulocyte and monocyte adsorption apheresis (GMA) is one therapeutic option for induction of remission in patients with inflammatory bowel diseases. Recently intensive GMA (2 sessions per week) was reported to be strikingly better than weekly GMA, both in remission rate and time to remission. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:22:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/\",\"name\":\"Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2011-04-11T13:58:00+00:00\",\"dateModified\":\"2021-07-09T11:22:18+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/","og_locale":"fr_FR","og_type":"article","og_title":"Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte","og_description":"Shingo Kato 1, Kazuhito Kani, Hidehiko Takabayashi, Ryuichi Yamamoto, Tomonari Ogawa, Akihiko Matsuda, Koji Yakabi, Intern ed. 2011;50(15):1591-3. Granulocyte and monocyte adsorption apheresis (GMA) is one therapeutic option for induction of remission in patients with inflammatory bowel diseases. Recently intensive GMA (2 sessions per week) was reported to be strikingly better than weekly GMA, both in remission rate and time to remission. […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:22:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/","name":"Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2011-04-11T13:58:00+00:00","dateModified":"2021-07-09T11:22:18+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-refractory-crohns-disease-by-intensive-granulocyte-and-monocyte-adsorption-apheresis-a-report-on-two-drug-refractory-cases\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/4035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=4035"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=4035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}